Skip to content

Clarifying the Confusion: Is Hydroxychloroquine a Steroid?

4 min read

According to leading medical sources like GoodRx and the American College of Rheumatology, hydroxychloroquine is not a steroid, though both have anti-inflammatory effects. They belong to entirely different drug classes and operate through distinct mechanisms to treat autoimmune conditions such as lupus and rheumatoid arthritis.

Quick Summary

Hydroxychloroquine is an antimalarial and DMARD that modulates the immune system differently from corticosteroids, a class of anti-inflammatory drugs mimicking cortisol. These medications have different structures, mechanisms, and side effect profiles.

Key Points

  • Not a Steroid: Hydroxychloroquine is an antimalarial and DMARD, which is a different class of medication from corticosteroids.

  • Distinct Mechanisms: Hydroxychloroquine slowly alters the immune response by affecting cellular pH and TLR signaling, while steroids rapidly suppress inflammation by altering gene transcription.

  • Steroid-Sparing Effect: Because it is safer for long-term use, hydroxychloroquine can reduce the amount of steroid needed, minimizing steroid-related side effects.

  • Different Onset of Action: Hydroxychloroquine takes weeks to months to become fully effective, whereas corticosteroids work quickly to control acute inflammation.

  • Combination Therapy: Healthcare providers may use both medications together during a severe disease flare, using steroids for immediate relief and HCQ for long-term maintenance.

  • Different Side Effects: Hydroxychloroquine has a different side effect profile (e.g., potential retinal toxicity with long-term use) compared to corticosteroids (e.g., weight gain, osteoporosis).

In This Article

A common point of confusion for patients is understanding the medications prescribed for complex inflammatory and autoimmune conditions. While both hydroxychloroquine and steroids are often used to reduce inflammation and suppress the immune system, they are not the same. They belong to different pharmacological classes, have distinct mechanisms of action, and carry different side effect profiles. Understanding these differences is crucial for patients managing conditions like lupus or rheumatoid arthritis.

What is Hydroxychloroquine?

Hydroxychloroquine, commonly known by the brand name Plaquenil, is a disease-modifying antirheumatic drug (DMARD) and an antimalarial. It was initially used to treat and prevent malaria but was later discovered to have immunomodulatory properties that benefit those with autoimmune diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

Unlike the rapid effects of steroids, hydroxychloroquine works gradually over weeks or even months. Its mechanism is complex and not fully understood, but it is known to accumulate in intracellular vesicles (endosomes and lysosomes), raising their pH. This change in pH disrupts several cellular processes, including antigen processing and the activation of Toll-like receptors (TLRs), which are key players in the body's innate immune response. By blocking TLR signaling, hydroxychloroquine reduces the production of pro-inflammatory cytokines, which are a driving force behind autoimmune inflammation.

What are Corticosteroids?

Corticosteroids, or steroids, are a class of powerful anti-inflammatory and immunosuppressive drugs. They are synthetic versions of cortisol, a hormone naturally produced by the adrenal glands. Examples include prednisone, methylprednisolone, and dexamethasone. Steroids are known for their rapid and dramatic effect in controlling inflammation, making them useful for treating acute disease flares.

Corticosteroids work by binding to intracellular glucocorticoid receptors (GR). The activated receptor-ligand complex then translocates to the cell's nucleus, where it can either:

  • Trans-activate: Increase the transcription of anti-inflammatory genes.
  • Trans-repress: Block the activity of pro-inflammatory transcription factors, such as NF-κB and AP-1, effectively shutting down the production of inflammatory proteins.

This potent effect, while beneficial in the short term, comes with a risk of significant side effects with prolonged use.

The Difference in Mechanism and Chemistry

The fundamental difference between hydroxychloroquine and steroids lies in their chemical structure and how they operate at a cellular level. The chemical structure of hydroxychloroquine is based on a quinoline nucleus, which is entirely different from the steroidal backbone of corticosteroids.

Furthermore, their mechanisms of action are divergent. Steroids directly interfere with gene transcription inside the cell's nucleus to suppress inflammatory responses. In contrast, hydroxychloroquine modifies cellular processes in endosomes and lysosomes, indirectly altering the immune response. This distinction explains why hydroxychloroquine's effects are slower to appear but are associated with fewer and less severe side effects than systemic corticosteroids.

Comparison of Hydroxychloroquine and Steroids

Feature Hydroxychloroquine Corticosteroids
Drug Class Antimalarial, Disease-Modifying Antirheumatic Drug (DMARD) Glucocorticoid, Anti-inflammatory
Mechanism of Action Alters cellular pH and inhibits TLR signaling, impacting antigen processing and reducing cytokine production. Binds to intracellular glucocorticoid receptors, affecting gene transcription to suppress multiple inflammatory pathways.
Onset of Effect Slow, taking several weeks to months to show full benefit. Fast-acting, providing rapid relief for acute inflammation.
Primary Uses Long-term management of lupus, rheumatoid arthritis, and certain skin conditions. Management of severe, acute inflammation in various conditions, including autoimmune flares.
Key Side Effects Nausea, diarrhea, stomach pain, and, rarely, retinal toxicity with long-term use. Weight gain, osteoporosis, increased infection risk, high blood pressure, and mood changes, especially with long-term use.

The "Steroid-Sparing" Role of Hydroxychloroquine

One of hydroxychloroquine's most valuable uses is as a "steroid-sparing" agent. For patients with chronic inflammatory diseases, high-dose or long-term steroid use is undesirable due to the risk of severe side effects. By incorporating hydroxychloroquine into a treatment plan, physicians can achieve sustained disease control while gradually tapering the steroid dose. This strategy allows patients to manage their condition with a much lower overall medication burden and fewer adverse effects.

Why are both sometimes used together?

In cases of a severe disease flare, a physician might prescribe a short, high-dose course of steroids to quickly suppress the intense inflammation and provide rapid symptom relief. Concurrently, they may start or continue hydroxychloroquine therapy to begin building its slower, longer-term anti-inflammatory effects. Once the hydroxychloroquine begins working effectively, the steroid dose can be safely reduced or stopped. This combination approach provides immediate relief while establishing a more sustainable and safer long-term treatment plan.

Conclusion: Different Tools for a Common Goal

In summary, hydroxychloroquine and corticosteroids are fundamentally different medications, despite both being effective in treating inflammatory conditions. Hydroxychloroquine is a DMARD and antimalarial with a slower, gentler mechanism, making it ideal for long-term disease management with a favorable side effect profile. Corticosteroids, in contrast, are powerful, fast-acting anti-inflammatories that are best reserved for short-term, acute symptom control due to their more significant risk of adverse effects. Understanding this distinction helps patients and healthcare providers make informed decisions to optimize treatment and minimize risk. Further information on these medications and many others can be found through authoritative sources like the National Institutes of Health.

Frequently Asked Questions

Yes, hydroxychloroquine is classified as a DMARD when used for conditions like rheumatoid arthritis and lupus.

The primary difference lies in their chemical structure, mechanism of action, and onset of effect. Hydroxychloroquine is a quinoline derivative with a slow, immunomodulatory effect, whereas steroids are synthetic cortisol derivatives with a rapid, potent immunosuppressive effect.

A doctor might prescribe both to manage a severe autoimmune flare. The steroid provides rapid relief from acute inflammation, while the slower-acting hydroxychloroquine begins to take effect for long-term disease control, allowing the steroid dose to be tapered down.

Yes, hydroxychloroquine generally has a more favorable long-term safety profile than corticosteroids. It allows for sustained disease management with a lower risk of severe side effects like osteoporosis and weight gain.

While hydroxychloroquine was investigated for COVID-19 early in the pandemic, major studies concluded it was not effective for treating or preventing the virus and had potentially dangerous side effects, especially with other drugs.

Corticosteroids are used to treat a wide range of inflammatory and autoimmune conditions, including asthma, allergies, lupus, and rheumatoid arthritis flares.

Yes, prolonged use of hydroxychloroquine can, in rare cases, cause retinal toxicity. This risk is higher with higher doses and long-term use, and requires regular eye exams for monitoring.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.